Publish in OALib Journal
APC: Only $99
Pancreatic poorly differentiated neuroendocrine tumors (PDNETs) are a subtype of neuroendocrine Tumors (NETs) clinically distinguished by their much more rapid growth and immunohistochemically diagnosed by having a higher Ki-67 cancer cell staining percentage compared to their well or intermediately differentiated NET counterparts. While standard first line treatment for metastatic well or intermediately differentiated pancreatic NETs typically involves octreotide acetate therapy, here I report, to my knowledge, the first case of a patient with a pancreatic PDNET with radiographic stabilization of his disease with octreotide acetate use alone. Octreotide acetate was chosen after first establishing that, based on his octreotide scan, receptors might be targeted using the octreotide analog.
Over the last several decades there has been a series of national economic/trade policies which has had a negative impact on employment, the middle class, organized labor, upward mobility, and the American Dream. This effort suggests that in order to compensate for economic/trade decisions which has led to a tremendous loss of all forms of employment in the USA, the power elite (both economic and political) have used the myth that the American Educational system has failed to educate, hence creating a skill gap and unemployment/underemployment.